Effects of lergotrile on schizophrenia and drug induced parkinsonism
Small, J.G.; Kellams, J.J.; Milstein, V.; Klapper, M.; Lemberger, L.
Communications in Psychopharmacology 1(5): 461-467
1977
ISSN/ISBN: 0145-5699 PMID: 23919 Document Number: 112092
Document emailed within 1 workday
Related Documents
Elie, R.; Gagnon, M.A.; Gauthier, R.; Jéquier, J.C. 1975: Effects of neuroleptic withdrawal on the drug-induced extrapyramidal syndrome of chronic schizophrenia L'Union Medicale du Canada 104(6): 909-914Shiio, Y. 2007: Drug-induced parkinsonism Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 8): 377-381
Pavletic, Z.S.; Bishop, M.R.; Markopoulou, K.; Wszolek, Z.K. 1996: Drug-induced parkinsonism after allogeneic bone marrow transplantation Bone Marrow Transplantation 17(6): 1185-1187
Grimes, J.D. 1982: Drug-induced parkinsonism and tardive dyskinesia in nonpsychiatric patients Canadian Medical Association Journal 126(5): 468
Shoulson, I. 1983: Carbidopa/levodopa therapy of coexistent drug-induced parkinsonism and tardive dyskinesia Advances in Neurology 37: 259-266
Nakamura, S.; Engel, J.; Goldstein, M. 1978: Blockade of lergotrile or apomorphine induced turning behavior by haloperidol and clozapine Communications in Psychopharmacology 2(3): 185-190
Ratner, A.; Woo, W.; Yelvington, D.; Torres, K. 1981: Effect of lergotrile mesylate and methysergide on morphine induced increase in prolactin release Proceedings of the Western Pharmacology Society 24: 335-339
Morozova, M.A.; Beniashvili, A.G.; Rupchev, G.E.; Lepilkina, T.A.; Starostin, D.S.; Brusov, O.S. 2008: Effects of the anticholinesterase drug neuromidin in patients with schizophrenia with marked neurocognitive deficits Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 108(11): 28-35
Bach, O.; Kästner, I. 1984: Undesired drug side effects and drug-induced damage. II. Centrally acting drugs Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 39(1): 1-6
Winkelman, A.C. 1977: Update on drug treatment of Parkinsonism American Family Physician 16(1): 118-120
Levin, I.I. 1994: "Drug-free vacations" in parkinsonism patients Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 94(5): 26-28
Thakore, J.H.; Mann, J.N.; Vlahos, I.; Martin, A.; Reznek, R. 2002: Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity 26(1): 137-141
Fujii, Y. 2001: Acute phase drug therapy and drug switching in the treatment of patients with schizophrenia Seishin Shinkeigaku Zasshi 103(12): 1030-1035
Parmar, R.C.; Valvi, C.V.; Kamat, J.R.; Vaswani, R.K. 2000: Chloroquine induced parkinsonism Journal of Postgraduate Medicine 46(1): 29-30
Durán, E.; Chacón, J.R. 2001: Parkinsonism probably induced by manganese Revista de Neurologia 33(5): 434-436
Oleĭnik, L.I. 1984: Vascular parkinsonism and current methods for its drug treatment Fel'dsher i Akusherka 49(3): 33-37
Coleman, J.H.; Hayes, P.E. 1975: Drug induced extrapyramidal effects--a review Diseases of the Nervous System 36(10): 591-593
Ryzhkova, M.N.; Tarasova, L.A. 1975: Pathogenesis and treatment of manganese induced Parkinsonism Gigiena Truda i Professional'nye Zabolevaniya (11): 31-34
Lutz, E.G. 1978: Neuroleptic-induced parkinsonism facilitated by alcohol Journal of the Medical Society of New Jersey 75(6): 473-474
Fruncillo, R.J. 1986: Toxin-induced parkinsonism: recent developments American Family Physician 33(3): 251-254